pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

nkarta-therapeutics PRESS RELEASE ARCHIVE

Jun 14, 2021

Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term

Jun 22, 2020

Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AACR) Virtual 2020 Annual Meeting II

Apr 27, 2020

Nkarta Therapeutics Appoints Two New Independent Directors

Jan 9, 2020

Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference

Dec 9, 2019

Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development

Nov 18, 2019

Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program

Sep 23, 2019

Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019

Sep 18, 2019

Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer

Sep 10, 2019

Nkarta Therapeutics Appoints Vice President of Regulatory Affairs

Sep 4, 2019

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Sep 4, 2019

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Apr 1, 2019

Nkarta Therapeutics Presents Data at AACR Demonstrating Proprietary NK Cell Engineering and Expansion Technology Enhances Potency and Cytotoxicity of NK Cells

Dec 10, 2018

Nkarta Therapeutics Announces Appointment of Matthew Plunkett, Ph.D., as Chief Financial Officer

Nov 27, 2018

Nkarta Therapeutics Appoints Kanya Rajangam, M.D., Ph.D, as Chief Medical Officer

Nov 9, 2018

Nkarta Therapeutics Reports Potent Natural Killer Cell Anti-Cancer Activity in Preclinical Tumor Model

Jul 9, 2018

Nkarta Therapeutics Expands Management Team and Establishes New Corporate Headquarters

Jun 11, 2018

Nkarta Therapeutics Announces Exclusive License to Natural Killer Cell Technology From National University of Singapore and St. Jude Children’s Research Hospital

Mar 1, 2018

Nkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of Growth

Google Analytics Alternative